Announcements

Job Offers

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

CAN (ON): TerrAscend appointed Ed Schutter to board of directors

TerrAscend has appointed Ed Schutter to its Board of Directors.

"Mr. Schutter is a seasoned executive with over thirty years of pharmaceutical industry experience," the team with the company explains. "He currently serves as Chief Executive Officer of Arbor Pharmaceuticals, an Atlanta, Georgia based specialty pharmaceutical company which markets prescription products for the cardiovascular, neuroscience and orphan/hospital markets. Arbor also has several branded prescription products in late-stage development."

“We are thrilled to welcome Ed to our Board at such a pivotal time in our Company’s growth,” said Jason Ackerman, Chief Executive Officer and Executive Chairman of TerrAscend. “Ed brings a tremendous amount of relevant Board experience and new ideas to the table. His experience in the U.S. and global pharmaceutical industry will serve TerrAscend well as we continue to build scale and accelerate our growth.”

Jason Wild, Chairman of TerrAscend, added, “As Chairman of Arbor, I have had the pleasure of working with Ed for over 10 years. He is bright, passionate, honest, and genuinely cares about the wellbeing of Arbor’s employees and patients. He has been a source of trusted advice to me, as it relates to TerrAscend over the last three years, and I am thrilled that he has joined our Board. His M&A experience will be particularly useful to us as we continue to grow.”

For more information:
TerrAscend
terrascend.com 


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber